针刺联合补阳还五汤治疗难治性面瘫的临床效果和安全性

Abstract
Figure/Table
References (20)
Related Citation (7)

Download: PDF (698 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To observe the clinical efficacy and safety of acupuncture combined with Buyang Huanwu Decoction in the treatment of refractory facial paralysis. Methods Seventy patients treated for refractory facial paralysis in Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine from January 2013 to December 2016 were selected, and divided into treatment group (35 cases) and control group (35 cases) by random number table method. The control group was treated with acupuncture therapy, while the treatment group was treated with Buyang Huanwu Decoction based on the treatment of control group, all the patients were treated for 1 month. The TCM syndrome score, facial nerve function rating scale and facial disability index score were recorded, the total effective rate and incidence of adverse events were observed. Results After 1 month of treatment, the total effective rate of the treatment group was 88.57%, which was higher than that of the control group (74.29%) (P ＜ 0.05). After treatment, the TCM symptom scores of the two groups were lower than those before treatment, and the score of treatment group after treatment was lower than that of the control group (P ＜ 0.05). The neurological function classification of the two groups after treatment was improved compared with those before treatment. After treatment, the neurological function classification of the treatment group was better than that of the control group (P ＜ 0.05). Facial disability index score and physical function social of the two groups were higher than those before treatment, and the score of the treatment group was higher than the control group (P ＜ 0.05). There was no statistically significant difference of adverse events between treatment group and control group (P ＞ 0.05). Conclusion Acupuncture combined with Buyang Huanwu Decoction can significantly improve symptoms, facial nerve function and facial disability index of refractory facial paralysis patients. Exact efficacy and good safety of the treatment therapy lay a solid foundation for the wide promotion.

Key words： Refractory facial paralysis Acupuncture Buyang Huanwu Decoction Therapeutic effects

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	TANG Zhengdong CUI Huashun SHEN Weidong

Cite this article:

TANG Zhengdong CUI Huashun SHEN Weidong. Clinical efficacy and safety of acupuncture combined with Buyang Huanwu Decoction in the treatment of refractory facial paralysis[J]. 中国医药导报, 2018, 15(18): 127-130.

URL:

http://www.yiyaodaobao.com.cn/EN/ OR http://www.yiyaodaobao.com.cn/EN/Y2018/V15/I18/127

[1] 熊年秀，彭夏红，涂群，等.中药封包热熨联合温针灸治疗风寒型周围性面瘫[J].郑州大学学报：医学版，2017， 52（4）：515-516.
[2] 袁佛良.中西医结合治疗周围性面瘫42例临床观察[J].中国民族民间医药杂志，2015，24（11）：132.
[3] Sullivan F，Daly F，Gagyor I. Antiviral agents added to corticosteroids for early treatment of adults with acute idiopathic facial nerve paralysis（Bell Palsy）[J]. JAMA，2016，316（8）：874.
[4] 王维治.神经病学[M].北京：人民卫生出版社，2013：276.
[5] 国家中医药管理局.中医病证诊断疗效标准[M].南京：南京大学出版社，1994：51-52.
[6] Kim SH，Jung AR，Kim SI，et al. Refractory granulomatosis with polyangiitis presenting as facial paralysis and bilateral sudden deafness [J]. J Audiol Otol，2016，20（1）：55.
[7] 袁佛良.中西医结合治疗周围性面瘫42例临床观察[J].中国民族民间医药杂志，2015，24（11）：132.
[8] 王新德.实用临床神经病学[M].北京：科学技术文献出版社，2007：66-67.
[9] 中华人民共和国卫生部.中药新药临床研究指导原则[M].北京：中国医药科技出版社，2002：77-78.
[10] N&T Ear. Antiviral treatment for Bell's palsy（idiopathic facial paralysis）[J]. Clinical Otolaryngology，2010，35（1）：55.
[11] Volk GF，Steigerwald F，Vitek P，et al. Facial disability index and facial clinimetric evaluation scale：validation of the german versions [J]. Laryngorhinootologie，2015，94（3）：163-168.
[12] 张莹莹，董翟华，骆许鹏.超短波，电针，补阳还五汤，牵正散及斑蝥外敷对周围性面瘫的诊治疗效探讨分析[J].山西中医学院学报，2016，17（6）：24-26.
[13] Yang J，Gao F，Zhang Y，et al. Buyang Huanwu Decoction（BYHWD）enhances angiogenic effect of mesenchymal stem cell by upregulating VEGF expression after focal cerebral ischemia [J]. J Mol Neurosci，2015，56（4）：898-906.
[14] Diamond EL，Abdel-Wahab O，Durham BH，et al. Anakinra as efficacious therapy for 2 cases of intracranial Erdheim-Chester disease [J]. Blood，2016，128（14）：1896-1898.
[15] 叶进.近10年中医治疗周围性面瘫的临床研究进展[C]//中华中医药学会.全国第二十三次仲景学说学术年会论文集，2015：277-279.
[16] 王陶，各廷秋，杨骏，等.针灸治疗难治性面瘫临床研究进展[J].针灸临床杂志，2016，32（11）：90-93.
[17] 王爱君，金瑛.针灸治疗贝尔氏面瘫132例时效性研究[J].中国现代医生，2016，54（15）：109-112.
[18] 孔岩，徐耑，郝亚南，等.简易面神经功能评价量表在特发性面神经麻痹评估中的信度和效度[J].中国康复理论与实践，2015，21（2）：224-227.
[19] 赵艳.面部运动联合分期针灸治疗贝尔面瘫患者的疗效研究[J].河北医学，2015，21（5）：749-752.
[20] 叶翛然，蔡剑飞，刘鸿.针刺配合叩刺拔罐治疗周围性面瘫的临床疗效[J].中国现代医生，2017，55（26）：126-129，133.